N - 4 - hydroxy - 3 - 2 - {n, N - dimetilaminometil) benzofuran - 2 - ilcarbonilamino ethoxy} benzamide and scheme to manage

摘要

N - 4 - hydroxy - 2 - {[2 - (n, N - dimetilaminometil benzofuran) ethoxy] - 2 - ilcarbonilamino} benzamide of formula (1) or one of its Salts added to a base or a pharmaceutically acceptable acid, alone or in association with Treatment of surgery, Chemo hormone therapy, or radioterapi For use in the treatment of cancer.Wherein administered during 4 consecutive days, this period being followed for 3 consecutive days without any Administration of the compound of formula (1), with the proviso that the treatment is not the FOLFOX Chemotherapy.